이 페이지를 로드하는 동안 오류가 발생한 것 같습니다.
지원팀에 전달되었습니다. 만약 문제가 지속될 경우 이메일 지원 위젯을 통해 다시 문의 부탁드립니다.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Revenue Multiple | 4.7x - 5.2x | 4.9x |
| Selected Fwd Revenue Multiple | 5.2x - 5.8x | 5.5x |
| Fair Value | ﷼20.56 - ﷼22.74 | ﷼21.65 |
| Upside | -17.2% - -8.4% | -12.8% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| Al Hammadi Holding Company | 4007 | SASE:4007 |
| Al-Modawat Specialized Medical Company | 9594 | SASE:9594 |
| Saudi Chemical Holding Company | 2230 | SASE:2230 |
| Scientific and Medical Equipment House Company | 4014 | SASE:4014 |
| Canadian General Medical Center Complex Company | 9518 | SASE:9518 |
| Twareat Medical Care Company | 9627 | SASE:9627 |
| Select LTM Revenue Multiple | ||||||||
| Benchmark Companies | ||||||||
| 4007 | 9594 | 2230 | 4014 | 9518 | 9627 | |||
| SASE:4007 | SASE:9594 | SASE:2230 | SASE:4014 | SASE:9518 | SASE:9627 | |||
| Historical Revenue Growth | ||||||||
| 5Y CAGR | 3.4% | NM- | 16.7% | 8.0% | NM- | NM- | ||
| 3Y CAGR | 6.6% | NM- | 23.2% | 7.8% | 16.0% | NM- | ||
| Latest Twelve Months | -1.9% | 5.7% | 31.3% | 9.8% | 21.5% | NM | ||
| Historical EBIT Profit Margin | ||||||||
| 5 Year Average Margin | 21.3% | 21.7% | 5.2% | 8.9% | 20.3% | 12.9% | ||
| Prior Fiscal Year | 29.1% | 20.7% | 6.5% | 8.3% | 21.0% | 18.0% | ||
| Latest Fiscal Year | 26.5% | 29.4% | 6.8% | 4.5% | 15.5% | 9.0% | ||
| Latest Twelve Months | 26.5% | 19.0% | 6.8% | 4.5% | 10.5% | 13.2% | ||
| Current Trading Multiples | ||||||||
| EV / LTM Revenue | 5.71x | 5.10x | 1.37x | 1.54x | 4.65x | 5.71x | ||
| EV / LTM EBIT | 21.5x | 26.8x | 20.2x | 34.5x | 44.4x | 43.1x | ||
| Price / LTM Sales | 5.78x | 5.25x | 1.14x | 1.43x | 5.00x | 5.67x | ||
| Low | Mid | High | ||||||
| Benchmark EV / LTM Revenue | 1.37x | 4.65x | 5.71x | |||||
| Historical EV / LTM Revenue | 0.00x | NM | 0.00x | |||||
| Selected EV / LTM Revenue | 4.67x | 4.92x | 5.16x | |||||
| (x) LTM Revenue | 175 | 175 | 175 | |||||
| (=) Implied Enterprise Value | 818 | 861 | 905 | |||||
| (-) Non-shareholder Claims * | (7) | (7) | (7) | |||||
| (=) Equity Value | 812 | 855 | 898 | |||||
| (/) Shares Outstanding | 40.0 | 40.0 | 40.0 | |||||
| Implied Value Range | 20.29 | 21.37 | 22.45 | |||||
| FX Rate: SAR/SAR | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 20.29 | 21.37 | 22.45 | 24.84 | ||||
| Upside / (Downside) | -18.3% | -14.0% | -9.6% | |||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | 4007 | 9594 | 2230 | 4014 | 9518 | 9627 | |
| Enterprise Value | 6,588 | 379 | 8,760 | 1,256 | 494 | 1,000 | |
| (+) Cash & Short Term Investments | 245 | 25 | 130 | 0 | 45 | 3 | |
| (+) Investments & Other | 135 | 0 | 2 | 0 | 0 | 0 | |
| (-) Debt | (304) | (13) | (1,587) | 0 | (8) | (9) | |
| (-) Other Liabilities | 0 | 0 | (12) | 0 | 0 | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 6,664 | 391 | 7,294 | 1,256 | 532 | 994 | |
| (/) Shares Outstanding | 160.0 | 23.8 | 843.2 | 30.0 | 77.0 | 40.0 | |
| Implied Stock Price | 41.65 | 16.46 | 8.65 | 41.85 | 6.91 | 24.84 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 41.65 | 16.46 | 8.65 | 41.85 | 6.91 | 24.84 | |
| Trading Currency | SAR | SAR | SAR | SAR | SAR | SAR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |